Yi Lin

71PUBLICATIONS
299CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical mycologyAutoimmunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (71)

|Aug 14, 2026
Review Article: Immune Effector Cell-Mediated Enterocolitis Following CAR-T Cell Therapy-Clinical Features, Pathophysiology and Management.

|Jul 21, 2026
Cytogenetics-based clinical trajectories in patients with MRD negativity post autologous transplant for multiple myeloma.

|Jun 23, 2026
Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma.

|Apr 17, 2026
Risk of AL Amyloidosis is Associated with Degree of Free Light Chain Elevation and Duration of Exposure.

|Mar 30, 2026
Management of hematological toxicities after BCMA-directed CAR-T cell therapy.

Joselle Cook, Supriya Gupta, Nadine Abdallah

|Mar 28, 2026
Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium.

Andrew J Portuguese, James A Davis, Shahzad Raza

Pageof 12

Frequent Collaborators

36 joint publications

Shaji Kumar

35 joint publications

Prashant Kapoor

34 joint publications

Taxiarchis V Kourelis

31 joint publications

David Dingli